These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 20379104

  • 1. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Koshino M, Kudou D, Okoshi Y, Obara N, Simizu S, Mukai HY, Suzukawa K, Hasegawa Y, Kojima H, Nagasawa T, Chiba S.
    Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
    [Abstract] [Full Text] [Related]

  • 2. [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Hong H, Aoyama Y, Yamamura R, Ohta T, Mugitani A, Yamane T, Hino M, Matsumoto M, Fujimura Y.
    Rinsho Ketsueki; 2006 Dec; 47(12):1528-32. PubMed ID: 17233471
    [Abstract] [Full Text] [Related]

  • 3. [Refractory thrombotic thrombocytopenic purpura successfully treated with a combination of rituximab and vincristine].
    Kaneko H, Matsumoto M, Okamoto K, Chyonabayashi K, Hishizawa M, Watanabe M, Fujimura Y, Tsudo M.
    Rinsho Ketsueki; 2007 Feb; 48(2):144-7. PubMed ID: 17370643
    [Abstract] [Full Text] [Related]

  • 4. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP.
    Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
    [Abstract] [Full Text] [Related]

  • 5. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
    Scully M, Cohen H, Cavenagh J, Benjamin S, Starke R, Killick S, Mackie I, Machin SJ.
    Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
    [Abstract] [Full Text] [Related]

  • 6. Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib.
    van Balen T, Schreuder MF, de Jong H, van de Kar NC.
    Eur J Haematol; 2014 Jan; 92(1):80-2. PubMed ID: 24118335
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
    Chemnitz JM, Uener J, Hallek M, Scheid C.
    Ann Hematol; 2010 Oct; 89(10):1029-33. PubMed ID: 20422413
    [Abstract] [Full Text] [Related]

  • 8. [Refractory thrombotic thrombocytopenic purpura achieving complete remission with rituximab treatment].
    Iino H, Ogawa Y, Yanagisawa K, Shimizu H, Mitsui T, Ishizaki T, Hayakawa M, Matsumoto M, Nojima Y, Handa H.
    Rinsho Ketsueki; 2017 Oct; 58(3):204-209. PubMed ID: 28381686
    [Abstract] [Full Text] [Related]

  • 9. A case series of atypical presentations of thrombotic thrombocytopenic purpura.
    Imanirad I, Rajasekhar A, Zumberg M.
    J Clin Apher; 2012 Oct; 27(4):221-6. PubMed ID: 22467376
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review.
    Harambat J, Lamireau D, Delmas Y, Ryman A, Llanas B, Brissaud O.
    Pediatr Crit Care Med; 2011 Mar; 12(2):e90-3. PubMed ID: 20625343
    [Abstract] [Full Text] [Related]

  • 11. [Successful rituximab treatment in an elderly patient with recurrent thrombotic thrombocytopenic purpura].
    Matsubara E, Yamanouchi J, Hato T, Takeuchi K, Niiya T, Yasukawa M.
    Rinsho Ketsueki; 2016 Jul; 57(7):869-72. PubMed ID: 27498731
    [Abstract] [Full Text] [Related]

  • 12. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
    Coppo P, Veyradier A.
    Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
    [Abstract] [Full Text] [Related]

  • 13. Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection.
    Mak SK, Lo KY, Lo MW, Chan SF, Lo KC, Wong YY, Tong GM, Wong PN, Ma ES, Wong AK.
    Hong Kong Med J; 2009 Jun; 15(3):201-8. PubMed ID: 19494376
    [Abstract] [Full Text] [Related]

  • 14. Two cases of refractory thrombotic thrombocytopenic purpura associated with collagen vascular disease were significantly improved by rituximab treatment.
    Kameda T, Dobashi H, Kittaka K, Susaki K, Yamaoka G, Arai K, Tokuda M, Ishida T.
    Clin Rheumatol; 2007 Dec; 26(12):2159-2162. PubMed ID: 17562094
    [Abstract] [Full Text] [Related]

  • 15. A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.
    Clark WF, Rock G, Barth D, Arnold DM, Webert KE, Yenson PR, Kelton JG, Li L, Foley SR, members of Canadian Apheresis Group.
    Br J Haematol; 2015 Jul; 170(2):208-17. PubMed ID: 25855259
    [Abstract] [Full Text] [Related]

  • 16. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab.
    Caramazza D, Quintini G, Abbene I, Malato A, Saccullo G, Lo Coco L, Di Trapani R, Palazzolo R, Barone R, Mazzola G, Rizzo S, Ragonese P, Aridon P, Abbadessa V, Siragusa S.
    Transfusion; 2010 Dec; 50(12):2753-60. PubMed ID: 20576013
    [Abstract] [Full Text] [Related]

  • 17. Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange.
    Narayanan P, Jayaraman A, Rustagi RS, Mahadevan S, Parameswaran S.
    Int J Hematol; 2012 Jul; 96(1):122-4. PubMed ID: 22552883
    [Abstract] [Full Text] [Related]

  • 18. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N, Rutherford C, Matevosyan K, Shen YM, Sarode R.
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [Abstract] [Full Text] [Related]

  • 19. [Thrombotic thrombocytopenic purpura during pregnancy refractory to plasma exchange and rituximab].
    Kaneda Y, Kitagawa J, Yamaguchi K, Matsumoto T, Nakamura N, Nakamura H, Ninomiya S, Kanemura N, Kasahara S, Hara T, Shimizu M, Tsurumi H.
    Rinsho Ketsueki; 2019 Nov; 60(3):209-212. PubMed ID: 31068517
    [Abstract] [Full Text] [Related]

  • 20. Current insight into thrombotic thrombocytopenic purpura.
    Verbeke L, Delforge M, Dierickx D.
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.